These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

722 related items for PubMed ID: 25434924

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson ADJ, Federico S, Gatz SA, Ortiz M, Lesa G, Scobie N, Gounaris I, Weiner SL, Weigel B, Unger TJ, Stewart E, Smith M, Slotkin EK, Reaman G, Pappo A, Nysom K, Norga K, McDonough J, Marshall LV, Ludwinski D, Ligas F, Karres D, Kool M, Horner TJ, Henssen A, Heenen D, Hawkins DS, Gore L, Bender JG, Galluzzo S, Fox E, de Rojas T, Davies BR, Chakrabarti J, Carmichael J, Bradford D, Blanc P, Bernardi R, Benchetrit S, Akindele K, Vassal G.
    Eur J Cancer; 2023 Sep; 190():112950. PubMed ID: 37441939
    [Abstract] [Full Text] [Related]

  • 27. How can attrition rates be reduced in cancer drug discovery?
    Moreno L, Pearson AD.
    Expert Opin Drug Discov; 2013 Apr; 8(4):363-8. PubMed ID: 23373702
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Drug development in oncology: a regulatory perspective.
    Augustus S.
    Am J Ther; 2011 Jul; 18(4):323-31. PubMed ID: 20335790
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. From class waivers to precision medicine in paediatric oncology.
    Pearson ADJ, Pfister SM, Baruchel A, Bourquin JP, Casanova M, Chesler L, Doz F, Eggert A, Geoerger B, Jones DTW, Kearns PR, Molenaar JJ, Morland B, Schleiermacher G, Schulte JH, Vormoor J, Marshall LV, Zwaan CM, Vassal G, Executive and Biology Committees of the Innovative Therapies for Children with Cancer European Consortium.
    Lancet Oncol; 2017 Jul; 18(7):e394-e404. PubMed ID: 28677575
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. European regulatory strategy for supporting childhood cancer therapy developments.
    Karres D, Lesa G, Ligas F, Benchetrit S, Galluzzo S, Van Malderen K, Sterba J, van Dartel M, Renard M, Sisovsky P, Wang S, Norga K.
    Eur J Cancer; 2022 Dec; 177():25-29. PubMed ID: 36323049
    [Abstract] [Full Text] [Related]

  • 35. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A, Felisi M, Catapano M, Baiardi P, Cipollina L, Ravera S, Bagnulo S, Reggio S, Rondini G.
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. At the frontier of progress for paediatric oncology: the neuroblastoma paradigm.
    Moreno L, Marshall LV, Pearson AD.
    Br Med Bull; 2013 Nov; 108():173-88. PubMed ID: 24211816
    [Abstract] [Full Text] [Related]

  • 38. Impact of the EU Paediatric Medicine Regulation on new anti-cancer medicines for the treatment of children and adolescents.
    Vassal G, de Rojas T, Pearson ADJ.
    Lancet Child Adolesc Health; 2023 Mar; 7(3):214-222. PubMed ID: 36682367
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Balancing research interests and patient interests: a qualitative study into the intertwinement of care and research in paediatric oncology.
    Dekking SA, van der Graaf R, Kars MC, Beishuizen A, de Vries MC, van Delden JJ.
    Pediatr Blood Cancer; 2015 May; 62(5):816-22. PubMed ID: 25728244
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.